John Quackenbush to Speak at CHI’s Bioinformatics & Cancerinformatics Conference, February 21-23, San Francisco, CA
Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session.
Needham, MA, January 12, 2012 --(PR.com)-- Cambridge Healthtech Institute (CHI) today announces that John Quackenbush, Ph.D., Professor, Biostatistics and Computational Biology, Cancer Biology Center for Cancer, Dana-Farber Cancer Institute, has accepted CHI’s invitation to speak at its inaugural Bioinformatics & Cancerinformatics conference to be held on February 21-23, 2012 at the Moscone North Convention Center in San Francisco, CA. This program is part of the Molecular Medicine Tri-Conference.
Dr. Quackenbush’s presentation entitled “The Road to Personalized Medicine is Paved with Data and Information” is scheduled for Thursday, February 23 at 8:35-9:05 a.m. Dr. Quackenbush is a leader in the fields of genomics and computational biology and the author of The Curiosity Guide to the Human Genome (2011). His presentation will explore the elements necessary to successfully develop an integrated program using genomics and medical data, together with other sources of information, to arrive at robust biomarkers that can be reliably used in a clinical setting.
The Bioinformatics & Cancerinformatics conference is one of the program offerings at CHI’s flagship event, the Molecular Medicine Tri-Conference (February 19-23). This international event features 2 partnering forums, 5 symposia, 18 short courses, and 12 core programs around 4 scientific channels: diagnostics, drug discovery & development, informatics, and cancer.
Over 3000 attendees and 150+ sponsors & exhibitors will gather in shared networking functions and in the exhibit/poster hall.
Advance registration discounts are available until January 13, 2012. To view the agenda, speaker line-up, and to register, please visit www.TriConference.com/Bioinformatics-Cancerinform
To inquire about sponsoring and/or exhibiting, contact Jon Stroup, 781-972-5483, jstroup@healthtech.com.
Writers and editors are encouraged to attend. To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.
About Cambridge Healthtech Institute (www.chicorporate.com)
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.
Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.
Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com
###
Dr. Quackenbush’s presentation entitled “The Road to Personalized Medicine is Paved with Data and Information” is scheduled for Thursday, February 23 at 8:35-9:05 a.m. Dr. Quackenbush is a leader in the fields of genomics and computational biology and the author of The Curiosity Guide to the Human Genome (2011). His presentation will explore the elements necessary to successfully develop an integrated program using genomics and medical data, together with other sources of information, to arrive at robust biomarkers that can be reliably used in a clinical setting.
The Bioinformatics & Cancerinformatics conference is one of the program offerings at CHI’s flagship event, the Molecular Medicine Tri-Conference (February 19-23). This international event features 2 partnering forums, 5 symposia, 18 short courses, and 12 core programs around 4 scientific channels: diagnostics, drug discovery & development, informatics, and cancer.
Over 3000 attendees and 150+ sponsors & exhibitors will gather in shared networking functions and in the exhibit/poster hall.
Advance registration discounts are available until January 13, 2012. To view the agenda, speaker line-up, and to register, please visit www.TriConference.com/Bioinformatics-Cancerinform
To inquire about sponsoring and/or exhibiting, contact Jon Stroup, 781-972-5483, jstroup@healthtech.com.
Writers and editors are encouraged to attend. To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.
About Cambridge Healthtech Institute (www.chicorporate.com)
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.
Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.
Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com
###
Contact
Cambridge Healthtech Institute
James Prudhomme
781-972-5400
www.chicorporate.com
James Prudhomme
781-972-5400
www.chicorporate.com
Contact
Categories